U.S., Sept. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07189390) titled 'The Bloom Infant Probiotic (BIP) Study' on Sept. 16.
Brief Summary: The goal of this clinical trial is to investigate whether administering a probiotic (Infloran(R)) to infants who received antibiotics in the first 28 days of life can restore or enhance their immune response to routine vaccines.
Antibiotic use in the first weeks of life can lower the levels of beneficial gut bacteria, such as bifidobacteria, which play a key role in immune function. As a result, infants treated with antibiotics may produce fewer antibodies after routine vaccinations, leaving them less protected against infections.
The main questions this study ai...